Physician profile
Scott B Hacking
NPI 1992712285
$22,099.58
in general payments reported to CMS, 2019-2025
45 companies · $4,822 in 2025
The $4,822 reported for 2025 was more than what 82% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,163 · 2020: $2,712 · 2021: $1,981 · 2022: $2,404 · 2023: $2,714 · 2024: $2,304 · 2025: $4,822.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,655 · Travel and Lodging: $2,185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,655.11 |
| Travel and Lodging | $2,185.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $9,534.88 | 2019-2025 | Watchman Flx, Watchman Access System, Versacross Access Solution |
| Abbott Laboratories | $3,066.23 | 2019-2025 | Aveir, Navitor, Tendril |
| Novartis Pharmaceuticals Corporation | $1,190.19 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,040.07 | 2019-2025 | Camzyos, Eliquis |
| Pfizer INC. | $996.61 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $966.57 | 2019-2024 | Xarelto |
| Amgen INC. | $655.73 | 2019-2025 | Repatha, Repatha |
| Medtronic, INC. | $638.88 | 2021-2025 | Azure Xt Dr Mri Surescan, Micra, Linq II |
| Boehringer Ingelheim Pharmaceuticals, INC. | $558.73 | 2019-2025 | Jardiance |
| Philips North America LLC | $427.21 | 2022-2025 | (Cm9) Amb Mon & Diag Und, Ambulatory Monitoring & Diagnostics Undivided, (5044) Mcot |
| Chiesi USA, INC. | $348.73 | 2019-2025 | Kengreal |
| Merck Sharp & Dohme LLC | $318.58 | 2021-2025 | Verquvo, Capvaxive, Winrevair |
| Actelion Pharmaceuticals US, INC. | $301.31 | 2021-2025 | Opsumit, Uptravi |
| Amarin Pharma, INC. | $171.56 | 2019-2022 | |
| Heartflow, INC. | $155.51 | 2024-2025 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Hacking listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.